UBS Group AG - INTEST CORP ownership

INTEST CORP's ticker is INTT and the CUSIP is 461147100. A total of 40 filers reported holding INTEST CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of INTEST CORP
ValueSharesWeighting
Q3 2023$224,259
-57.8%
14,783
-27.0%
0.00%
Q2 2023$532,002
+584.4%
20,259
+440.5%
0.00%
Q1 2023$77,734
+158.5%
3,748
+28.4%
0.00%
Q4 2022$30,066
+43.2%
2,919
+7.9%
0.00%
Q3 2022$21,000
+61.5%
2,706
+40.2%
0.00%
Q2 2022$13,000
+8.3%
1,930
+68.0%
0.00%
Q1 2022$12,000
+20.0%
1,149
+45.4%
0.00%
Q4 2021$10,000790
+19650.0%
0.00%
Q2 2021$0
-100.0%
4
-99.8%
0.00%
Q1 2021$21,000
+40.0%
1,777
-23.5%
0.00%
Q4 2020$15,000
+650.0%
2,324
+357.5%
0.00%
Q3 2020$2,000
-66.7%
508
-70.1%
0.00%
Q2 2020$6,000
+500.0%
1,700
+614.3%
0.00%
Q1 2020$1,000
-94.1%
238
-91.7%
0.00%
Q4 2019$17,000
+41.7%
2,851
+6.4%
0.00%
Q3 2019$12,000
+1100.0%
2,680
+1164.2%
0.00%
Q1 2019$1,0000.0%212
+40.4%
0.00%
Q4 2018$1,000
-87.5%
151
-86.0%
0.00%
Q3 2018$8,000
-11.1%
1,077
-22.0%
0.00%
Q1 2018$9,000
-50.0%
1,380
-32.1%
0.00%
Q4 2017$18,000
+38.5%
2,033
+0.3%
0.00%
Q1 2017$13,000
+550.0%
2,026
+431.8%
0.00%
Q4 2016$2,000
-77.8%
381
-83.0%
0.00%
Q3 2016$9,000
+28.6%
2,236
+30.0%
0.00%
Q2 2016$7,0000.0%1,720
+4.3%
0.00%
Q3 2015$7,000
-61.1%
1,649
-61.1%
0.00%
Q2 2015$18,000
+63.6%
4,238
+62.1%
0.00%
Q1 2015$11,000
+83.3%
2,615
+98.7%
0.00%
Q4 2014$6,0001,3160.00%
Other shareholders
INTEST CORP shareholders Q2 2019
NameSharesValueWeighting ↓
Juniper Investment Company, LLC 447,830$9,287,9946.79%
Pacific Ridge Capital Partners, LLC 452,199$9,378,6072.31%
BARD ASSOCIATES INC 195,975$4,064,5221.68%
EAM Investors, LLC 173,695$3,602,4340.71%
THOMPSON DAVIS & CO., INC. 15,300$317,3220.41%
AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP 18,153$426,7620.39%
ESSEX INVESTMENT MANAGEMENT CO LLC 102,918$2,134,5190.31%
Truvestments Capital LLC 24,598$510,1630.27%
STANSBERRY ASSET MANAGEMENT, LLC 45,971$953,4390.18%
PERRITT CAPITAL MANAGEMENT INC 12,500$259,2500.14%
View complete list of INTEST CORP shareholders